Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis.

Integrin-linked kinase (ILK) is an intracellular serine/threonine protein kinase that regulates cell adhesion, survival, and epithelial-to-mesenchymal transition (EMT). In this study, we investigated the kinase activity of ILK during tubular EMT induced by TGF-beta1 and examined the therapeutic potential of an ILK inhibitor in obstructive nephropathy. TGF-beta1 induced a biphasic activation of ILK in renal tubular epithelial cells, with rapid activation starting at 5 min and the second wave of activation peaking at 24 h; the latter paralleled the induction of ILK protein expression. Pharmacologic inhibition of ILK with small-molecule inhibitor QLT-0267 abolished TGF-beta1-induced phosphorylation of Akt and glycogen synthase kinase-3beta, suppressed cyclin D1 expression, and largely restored the expression of E-cadherin and zonula occludens 1. Inhibition of ILK also blocked TGF-beta1-mediated induction of fibronectin, Snail1, plasminogen activator inhibitor 1, and matrix metalloproteinase 2. In a mouse model of obstructive nephropathy, administration of QLT-0267 inhibited beta-catenin accumulation; suppressed Snail1, alpha-smooth muscle actin, fibronectin, vimentin, and type I and type III collagen expression; and reduced total tissue collagen content. Inhibition of ILK did not affect kidney structure or function in normal mice. These findings suggest that increased ILK activity mediates EMT and the progression of renal fibrosis. Pharmacologic inhibition of ILK signaling may hold therapeutic potential for fibrotic kidney diseases.

[1]  Youhua Liu,et al.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. , 2008, The American journal of pathology.

[2]  Kebin Hu,et al.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. , 2007, The Journal of clinical investigation.

[3]  A. Phillips,et al.  Inhibition of Integrin-Linked Kinase via a siRNA Expression Plasmid Attenuates Connective Tissue Growth Factor-Induced Human Proximal Tubular Epithelial Cells to Mesenchymal Transition , 2007, American Journal of Nephrology.

[4]  H. Itoh,et al.  Snail1 is involved in the renal epithelial-mesenchymal transition. , 2007, Biochemical and biophysical research communications.

[5]  P. Erne,et al.  Integrin‐linked kinase is an essential mediator for T‐cadherin‐dependent signaling via Akt and GSK3β in endothelial cells , 2007 .

[6]  Youhua Liu,et al.  PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase. , 2007, Journal of the American Society of Nephrology : JASN.

[7]  S. Dedhar,et al.  Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. , 2007, Journal of the American Society of Nephrology : JASN.

[8]  A. Oloumi,et al.  Modulation of Wnt3a-mediated nuclear β-catenin accumulation and activation by integrin-linked kinase in mammalian cells , 2006, Oncogene.

[9]  Youhua Liu,et al.  Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  M. Nieto,et al.  Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney , 2006, The EMBO journal.

[11]  F. Strutz,et al.  Renal fibroblasts and myofibroblasts in chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[12]  A. Fogo,et al.  Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  D. Stolz,et al.  Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. , 2006, Journal of the American Society of Nephrology : JASN.

[14]  Matthias Kretzler,et al.  Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  Youhua Liu,et al.  Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.

[16]  Kebin Hu,et al.  Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator–Activated Receptor-γ Agonists , 2005 .

[17]  G. Mills,et al.  Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma , 2005, Molecular Cancer Therapeutics.

[18]  Chuanyue Wu.  PINCH, N(i)ck and the ILK: network wiring at cell-matrix adhesions. , 2005, Trends in cell biology.

[19]  M. Rastaldi,et al.  Functional consequences of integrin-linked kinase activation in podocyte damage. , 2005, Kidney international.

[20]  Chuanyue Wu.  The PINCH-ILK-parvin complexes: assembly, functions and regulation. , 2004, Biochimica et biophysica acta.

[21]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[22]  D. Lovett,et al.  Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. , 2003, The American journal of pathology.

[23]  Junwei Yang,et al.  Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  Lida Guo,et al.  Regulation of fibronectin matrix deposition and cell proliferation by the PINCH‐ILK‐CH‐ILKBP complex , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[26]  E. Hay,et al.  DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.

[27]  A. Woods,et al.  The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. , 2001, The American journal of pathology.

[28]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[29]  R. Wanke,et al.  Integrin linked kinase as a candidate downstream effector in proteinuria , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Dedhar,et al.  Regulation of Protein Kinase B/Akt-Serine 473 Phosphorylation by Integrin-linked Kinase , 2001, The Journal of Biological Chemistry.

[31]  C. Sutherland,et al.  Ca2+-independent Smooth Muscle Contraction , 2001, The Journal of Biological Chemistry.

[32]  A. Eddy.  Molecular basis of renal fibrosis , 2000, Pediatric Nephrology.

[33]  S. Dedhar,et al.  The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9) , 2000, Oncogene.

[34]  L. Donehower,et al.  The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3β and cAMP-responsive Element-binding Protein-dependent Pathways* , 2000, The Journal of Biological Chemistry.

[35]  Y. Tu,et al.  The LIM-Only Protein PINCH Directly Interacts with Integrin-Linked Kinase and Is Recruited to Integrin-Rich Sites in Spreading Cells , 1999, Molecular and Cellular Biology.

[36]  J. Woodgett,et al.  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Dedhar,et al.  Integrin-linked Protein Kinase Regulates Fibronectin Matrix Assembly, E-cadherin Expression, and Tumorigenicity* , 1998, The Journal of Biological Chemistry.

[38]  S. Dedhar,et al.  Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.

[39]  P. Erne,et al.  Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  K. Legate,et al.  ILK, PINCH and parvin: the tIPP of integrin signalling , 2006, Nature Reviews Molecular Cell Biology.

[41]  S. Dedhar,et al.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK , 2005, Nature Reviews Cancer.

[42]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[43]  Junwei Yang,et al.  Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. , 2003, The Journal of clinical investigation.

[44]  Junwei Yang,et al.  Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. , 2002, Journal of the American Society of Nephrology : JASN.

[45]  C. Sutherland,et al.  Ca-independent Smooth Muscle Contraction A NOVEL FUNCTION FOR INTEGRIN-LINKED KINASE* , 2001 .